drugset

drugset / Trial / NCT06284265

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

NCT06284265 ↗

Phase 3 Active not recruiting 415 enrolled Materia Medica Holding

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Clinical Trial of the Efficacy and Safety of Raphamin in Prevention of Recurrences of Chronic Bacterial Cystitis

Timeline

Start: 2023-10-16
Primary completion: 2026-12-31
Completion: 2026-12-31

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Raphamin	Unknown	—	Oral

Indications